๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Chemotherapy for malignant gliomas?

โœ Scribed by Dr. Schold

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
225 KB
Volume
25
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Molecularly targeted therapy for maligna
Molecularly targeted therapy for malignant glioma
โœ Sith Sathornsumetee; David A. Reardon; Annick Desjardins; Jennifer A. Quinn; Jam ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 473 KB

## Abstract Malignant gliomas are relatively uncommon but lethal cancers. Despite recent research efforts in cancer therapy, the prognosis of patients with malignant gliomas has remained dismal. Understanding the molecular pathogenesis of glioma may lead to a rational development of new therapies.

Combination chemotherapy for disseminate
Combination chemotherapy for disseminated malignant melanoma
โœ John J. Costanzi; V. K. Vaitkevicius; Joseph M. Quagliana; Barth Hoogstraten; Ch ๐Ÿ“‚ Article ๐Ÿ“… 1975 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 389 KB ๐Ÿ‘ 2 views

BCNU, hydroxyurea, a n d imidazole carboxamide (DTIC) were administered to 89 patients with disseminated malignant melanoma. A response rate of 27% was observed. The addition of vincristine in another 89 patients did not significantly improve the response rate (30%). This includes patients who died